scispace - formally typeset
P

Pamela Blaikie

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  5
Citations -  2551

Pamela Blaikie is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Phosphorylation & Neovascularization. The author has an hindex of 5, co-authored 5 publications receiving 2481 citations.

Papers
More filters
Journal ArticleDOI

Integrin β4 signaling promotes tumor angiogenesis

TL;DR: Genetic evidence is provided that α6β4 signaling promotes the onset of the invasive phase of pathological angiogenesis and hence identifies a novel target for antiangiogenic therapy.
Journal ArticleDOI

Tyrosine Phosphorylation of the β4 Integrin Cytoplasmic Domain Mediates Shc Signaling to Extracellular Signal-regulated Kinase and Antagonizes Formation of Hemidesmosomes

TL;DR: It is suggested that β4 Tyr1526 interacts in a phosphorylation-dependent manner with the PTB domain of Shc, which is required for subsequent tyrosine phosphorylated protein Shc and signaling to ERK but not formation of hemidesmosomes.
Journal ArticleDOI

α5β1 Integrin Activates an NF-κB-Dependent Program of Gene Expression Important for Angiogenesis and Inflammation

TL;DR: GeneCalling suggests that engagement of the α5β1 integrin promotes an NF-κB-dependent program of gene expression that coordinately regulates angiogenesis and inflammation.
Journal ArticleDOI

Targeted Deletion of the Integrin β4 Signaling Domain Suppresses Laminin-5-Dependent Nuclear Entry of Mitogen-Activated Protein Kinases and NF-κB, Causing Defects in Epidermal Growth and Migration

TL;DR: Evidence is provided that β4 signaling promotes epidermal growth and wound healing through a previously unrecognized effect on nuclear translocation of NF-κB and mitogen-activated protein kinases.